|
Form
|
|
(Filer)
|
Received
(
Period
)
|
| 424B2 |
 |
MORGAN STANLEY |
11/19/09 |
| FWP |
|
MORGAN STANLEY |
11/19/09 |
| FWP |
|
MORGAN STANLEY |
11/19/09 |
| FWP |
|
MORGAN STANLEY |
11/17/09 |
| 424B2 |
|
MORGAN STANLEY |
11/17/09 |
| 424B2 |
|
MORGAN STANLEY |
11/17/09 |
| FWP |
|
MORGAN STANLEY |
11/16/09 |
| 13F-HR |
|
MORGAN STANLEY |
11/16/09 (09/30/09) |
| SC 13G |
|
KKR FINANCIAL HOLDINGS LLC (MORGAN STANLEY) |
11/16/09 |
| SC 13G |
|
PRANA BIOTECHNOLOGY LTD(MORGAN STANLEY) |
11/16/09 |
| 4 |
|
TRANSMONTAIGNE PARTNERS L.P.(MORGAN STANLEY) |
11/13/09 (11/13/09) |
| SC 13D/A |
|
TRANSMONTAIGNE PARTNERS L.P.(MORGAN STANLEY) |
11/13/09 |
| 424B2 |
|
MORGAN STANLEY |
11/13/09 |
| 424B2 |
|
MORGAN STANLEY |
11/13/09 |
| 424B2 |
|
MORGAN STANLEY |
11/13/09 |
| 4 |
|
CYCLACEL PHARMACEUTICALS, INC.(MORGAN STANLEY) |
11/12/09 (11/10/09) |
| FWP |
|
MORGAN STANLEY |
11/12/09 |
| FWP |
|
MORGAN STANLEY |
11/12/09 |
| 424B2 |
|
MORGAN STANLEY |
11/12/09 |
| 4 |
|
MORGAN STANLEY(MACK JOHN J) |
11/10/09 (11/09/09) |